Interpath Pty Ltd is a globally successful Australian company with a vast product portfolio which includes the making of Joint XL. The company has both medical and veterinary health divisions, and is an industry leader specializing in scientific research and development for the treatment of joint tissue and cellular inflammation diseases, namely Osteoarthritis